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ABSTRACT
Objective: In the present study, evaluation of the methanol extract of Spatoglossum asperum, brown marine algae on the analgesic activity using 
animal model was focussed.
Methods: Acetic acid-induced writhing test on Wistar albino rats at a dosage of 10 mg/kg body weight of algal extract have been carried out. It showed 
significant analgesic activity by reducing the number of acetic acid-induced writhing.
Results: The animals at a dosage of 10 mg/kg body weight exhibited, 70.52% of the animals were protected using S. asperum extract, on the other 
hand, the standard, diclofenac protected 84.21% of the animals. The results are statistically significant at p<0.001, and the investigation revealed 
dose-dependent significant activity in comparison with standard and control.
Conclusion: Hence, it can be concluded that the methanol extracts of the brown alga S. asperum have potent analgesic activity at moderate doses.
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INTRODUCTION
An analgesic or painkiller is any member of the group of drugs used 
to achieve (analgesia) relief from pain [1]. For neuropathic pain, 
traditional analgesics are less effective, and the drugs based on tricyclic 
antidepressants and anticonvulsants could be often showed benefit as 
analgesics [2]. Analgesia is associated with several pathological conditions.
The drug with lesser side effects would be a viable option when selecting 
a drug for the treatment of any ailments. Several ongoing studies around 
the globe have been involved to identify the healing agents based on 
natural sources. Consequently, there are many natural products that 
exhibit analgesic properties with relatively low incidences of side effects 
have been reported [3,4]. An increasing number of studies on the drugs 
of marine origin are demonstrating that many compounds produced by 
marine life have useful pharmacological activities. Among these organisms, 
the macroalgae are considered to be a rich source of bioactive substances 
suitable for therapeutic medical applications in analgesics [5-9].
Among the algae, brown algae are one of the most interesting phyla with 
respect to pharmacologically active compounds, were investigated widely 
in the past decade [10]. Nevertheless, there are many natural products that 
exhibit anti-inflammatory and analgesic properties and have relatively 
low incidences of side effects. An increasing number of studies on marine 
flora and fauna are demonstrating that many compounds produced 
by marine life have useful pharmacological activities. Among these 
organisms, the macroalgae are considered to be a rich source of bioactive 
substances suitable for therapeutic medical applications including 
use as an antiprotozoal [8], antibacterial [11-16], antifungal [17-22], 
antiviral [23], antioxidant [24-26], antidiabetic [27-29], anti-
inflammatory [23], and analgesics [5,7,9].
METHODS
Sample collection and preparation
The samples of experimental marine brown alga, Spatoglossum 
asperum was collected from the Mandapam coast (Lat. 09˚ 17.417’N; 
Long. 079˚ 08.558’E) of the Gulf of Mannar. The alga was authenticated 
by the monograph of Phaeophyceae [30]. Then, the alga was washed 
thoroughly with sterilized seawater to remove extraneous materials. 
The sample was shade dried to constant weight obtained and ground. 
The powdered samples were stored in an airtight container for future 
use.
Preparation of algal extracts
About 50 g of dried seaweed powder was soaked in the methanol 
solvent (1:3 w/v) and kept in a hot air oven overnight at 323 K, and the 
extracts were collected and concentrated. The extract was then filtered 
through a Buchner funnel with Whatman No.1 filter paper. The filtrate 
was evaporated to dryness under pressure using a rotary vacuum 
evaporator at 323 K, and the crude extracts were weighed. The yield 
of the powdered extract obtained was 5 g (yield: 10%) in methanol 
solvent. These crude extracts were then tested for their analgesic 
activity.
Selection of animals
Wistar albino rats, weighing 180–220 g of their body weight were 
selected for writhing analgesic method by Eddy’s hot plate method 
and carrageenan-induced rat paw edema antiinflammatory effects. 
They were housed in polypropylene cages and maintained in standard 
laboratory conditions.
Acetic acid induced writhing test
The methods of Koster et al. (1959); Williamson et al. (1996) and 
García et al. (2004) were used [31-33]. Mice were used in three animals 
per group per dose of methanolic extract of S. asperum. The animals 
were kept individually in transparent perspex cages (25 cm × 15 
× 15 cm) for 30 min to acclimatize to their new environment before 
the commencement of the experiment. Control mice were pre-treated 
with normal saline in a volume of 1 mL/100 g of body weight, and after 
15 min each mouse was injected with 0.2 mL of 3% acetic acid. 5 min 
after the administration of acetic acid, the writhes were counted for 
20 min. Other groups of animals were pre-treated with algal extract, 
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15 min before injecting them intraperitoneally with 0.2 mL of 3% 
acetic acid. All experiments were performed between 08:00 and 16:00 
h in a quiet laboratory with an ambient temperature of 298±2 K. The 
ability of the algal extract was significantly reduced the number of 
acetic acid-induced writhes was taken as an analgesic activity. Animal 
experiments were performed in accordance with the CPCSEA norms 
and are approved by the Institute of Animal Ethical Committee (IAEC) 
No: IAEC/KMCP/153/FT/9599/2013-2014.
Statistical analysis
All animal experiments were performed with at least 7 mice per group, 
and the highest and lowest values were discarded. Data are presented 
as means± standard error. The significance of the results was calculated 
using one-way ANOVA using SPSS 17.0, and the differences were 
deemed statistically significant at p<0.01.
RESULTS
The methanol extract of S. asperum (10 mg/kg body weight) showed 
significant analgesic activity by reducing the number of acetic acid-
induced writhes (Table 1). The analgesic activity of S. asperum at a dose 
of 10 mg/kg body weight on acetic acid-induced writhing reflex could 
be clearly observed and nearly, 70.52% of the animals were protected 
as against S. asperum, whereas 84.21% by diclofenac (10 mg/kg body 
weight), a standard peripherally acting analgesic drug. The observed 
results are statistically significant at p<0.001. Many studies have 
found interesting biological activities in polar fractions from marine 
algae [34], and similar results were also obtained in our study.
The results of the present study showed a presence of triterpenes 
and steroids. Some of these compounds such as phenols, terpenes, 
polysaccharides, and steroids have been reported to possess anti-
edematous effects [23,35-41]. In agreement with these reports, it is 
possible that such compounds are present in the methanol extract of 
S. asperum and are able to inhibit the synthesis, release of inflammatory 
mediators involved in inflammation.
DISCUSSION
The present study demonstrated that the extracts, as well as structurally 
diverse compounds obtained from marine brown and green seaweeds, 
have been shown to inhibit inflammation [42]. The compounds in the 
seaweed extracts may play as competitive inhibitors of cyclooxygenase 
or lipoxygenase in an inflammation reaction, resulting in decreased 
production of prostaglandins and leukotrienes [43,44].
The analgesic test used in the present study was chosen to test the 
different nociceptors stimuli, namely cutaneous thermic and chemical 
visceral stimuli [45]. In acetic acid-induced abdominal writhing causes 
analgesia by liberating endogenous substances and many others excite 
pain to the never-ending. Based on the percentage inhibition on the 
number of writhes obtained with different doses of methanol extract 
of S. asperum, it was found that the intensity of the analgesic effect was 
similar to that of the diclofenac. Diclofenac and related drugs can inhibit 
cyclooxygenase in peripheral tissues, thus interfering with mechanical 
transduction in primary afferent nociceptors. The ostagladina amplify 
the pain mechanism and enhance vascular permeability while the 
leukotrienes contract smooth muscle of blood vessels. Prostaglandins 
also enhance the vascular permeability and mediate pro-inflammatory 
and allergic responses [46,47]. The results of the present study showed 
that all the doses of the methanol extract of S. asperum produce 
a significant analgesic effect which may be due to the release of 
endogenous substances that stimulate pain in nerve endings similar 
to diclofenac. The methanol extract of S. asperum antagonized the pain 
produced by the acetic acid analgesic test method; it is possible that the 
seaweed produces its analgesic activity both peripherally and centrally.
The treatment of animals with the methanol extracts of S. asperum has 
shown significant inhibition of the writhing induced by 1.0% acetic 
acid solution. The maximum reduction in the number of writhing 
was 70.52%, although the dose required to be higher than the acetic 
acid dose required for a similar effect. Nevertheless, all doses given 
were found to be more potent. The doses of positive control showed 
the percentage of reductions in the number of writhing of 84.21%. 
The search for new metabolites from marine organisms has resulted 
in the isolation of some compounds such as terpenes, peptides, and 
sulfated carbohydrates that exhibit analgesic effects [7,48,49]. The 
analgesic activity observed may be associated with the presence of such 
compounds and other secondary metabolites in the methanolic extract 
of S. asperum, which are able to inhibit the release of endogenous 
mediators in response to acetic acid.
In the present investigation, confirmed that the methanolic extract of 
S. asperum has potent anti-inflammatory activity at moderate doses. 
This result suggests that the constituents in the algal extract could 
inhibit chemical mediators responsible for inflammation and that the 
inhibitory role in the migration of leukocytes to the site of inflammation 
is a strong indication in this study. This could, therefore, support the 
anti-inflammatory property of the S. asperum. Therefore, the results 
possess significant analgesic activity as compared to the control group 
in the pain model in vivo, with no serious toxic effect at moderate doses. 
The present findings reinforce the claims of the health-care industry 
and indigenous medicine that S. asperum can be used as a remedy 
for inflammation-related symptoms. Further, chemical analysis of the 
methanolic extract of S. asperum is necessary to isolate and identify 
the bioactive compounds that may have potential applications in 
therapeutic fields as analgesics. It is also understood that the rich 
diversity of marine biota with its unique physiological adaptations 
to the harsh marine environment provides a fruitful source for the 
discovery of life-saving drugs.
CONCLUSION
The marine brown alga S. asperum antagonized the pain produced 
by acetic acid writhing test methods; it is possible that the seaweed 
produces its analgesic activity both peripherally and centrally. The 
present study confirmed that the methanol extracts of the brown alga 
S. asperum have potent analgesic activity at moderate doses. This result 
also suggests that the constituents in this extract could inhibit chemical 
mediators responsible for analgesic activity is a strong indication in this 
study.
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Table 1: Analgesic activities of methanolic extract of S. asperum on acetic acid‑induced writhing reflux in rats
Groups Dose (mg/kg) No. of 
writhing
% reduction in 
reaction time
Normal control (Group I) Inject 1% v/v acetic acid 1 mL/100 g of body weight 38.0±3.5 -
Positive control diclofenac sodium (Group II) 10 mg/kg/body weight I. P. diclofenac sodium 6.0±0.8 84.21%**
Treatment control (methanolic extract of 
S. asperum (Group III)
10 mg/kg/body weight administered through orally 11.2±2.0 70.52%**
Values are expressed as mean±standard error of the mean. Values were found out by using one-way ANOVA followed by Newman’s cause multiple range tests. **Values 
were considered significant at P<0.001. S. asperum: Spatoglossum asperum
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